ASSOCIATING eNOS GENE VARIANTS WITH COVID-19 SUSCEPTIBILITY IN THE TURKISH POPULATION

被引:0
|
作者
Senkal, Naci [1 ]
Oyaci, Yasemin [2 ]
Cebeci, Timurhan [1 ]
Konyaoglu, Hilal [1 ]
Kose, Murat [1 ]
Onel, Mustafa [3 ]
Medetalibeyoglu, Alpay [1 ]
Sayin, Yesil Gozde [4 ]
Pehlivan, Mustafa [5 ]
Pehlivan, Sacide [2 ]
Isoglu-Alkac, Ummihan [6 ]
Tukek, Tufan [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Med Biol, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Microbiol, Istanbul, Turkiye
[4] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye
[5] Gaziantep Univ, Fac Med, Dept Haematol, Gaziantep, Turkiye
[6] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkiye
关键词
COVID-19; nitric oxide synthase; variant; RFLP-PCR; NITRIC-OXIDE SYNTHASE; SMALL RNA; POLYMORPHISMS; DISEASES; LOCALIZATION; SEVERITY; IMPACT; T-786C; G894T;
D O I
10.26650/IUITFD.1211888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: COVID-19 is a serious respiratory and vascular disease that impairs the protective function of the endothelial barrier. Endothelial nitric oxide synthase (eNOS), the most important isoform for NO production, is mostly expressed in endothelial cells. Therefore, this study aims to evaluate whether eNOS G894T and variable tandem repeat number (VNTR) functional variants show predisposition to developing COVID-19.Materials and Methods: The study includes a total of 384 subjects (284 COVID-19 patients and 100 healthy controls). Two eNOS gene variants (G894T and VNTR) were genotyped using the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods, with the results being evaluated using statistical methods.Results: A significant association has been identified between eNOS G894T and COVID-19. For the eNOS G894T variant, the T/T genotype (p=0.035) and T allele carriers (p=0.030) appear to have an increased risk of developing COVID-19. The eNOS G894T G/G genotype (p=0.030) was more common in the control group compared to the patient group. No significant difference was found between groups regarding the eNOS VNTR genotype and allele frequencies (p>0.05). The genotypes of the patient and control groups for these variants were in Har-dy-Weinburg equilibrium (HWE).Conclusion: These results provide evidence supporting the hy-pothesis that the eNOS G894T variant is associated with an in-creased risk of developing COVID-19 in the Turkish population. These findings may lead to the emergence of new treatment op-tions. Further research is required to understand the molecular mechanisms involved in the pathogenesis of the disease.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [41] Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
    Waman, Vaishali P.
    Ashford, Paul
    Lam, Su Datt
    Sen, Neeladri
    Abbasian, Mahnaz
    Woodridge, Laurel
    Goldtzvik, Yonathan
    Bordin, Nicola
    Wu, Jiaxin
    Sillitoe, Ian
    Orengo, Christine A.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review
    Hoseinnezhad, Taraneh
    Soltani, Nasrin
    Ziarati, Sarina
    Behboudi, Emad
    Mousavi, Mohammad Javad
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (1-2)
  • [43] Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity
    Mozner, Orsolya
    Szabo, Edit
    Kulin, Anna
    Varady, Gyorgy
    Moldvay, Judit
    Vass, Vivien
    Szentesi, Andrea
    Janosi, Agoston
    Hegyi, Peter
    Sarkadi, Balazs
    PLOS ONE, 2025, 20 (01):
  • [44] The Role of PON1 Variants in Disease Susceptibility in a Turkish Population
    Abudayyak, Mahmoud
    Boran, Tugce
    Tukel, Rumeysa
    Oztas, Ezgi
    Ozhan, Gul
    GLOBAL MEDICAL GENETICS, 2020, 7 (02): : 41 - 46
  • [45] Covid-19: virology, variants, and vaccines
    Young, Megan
    Crook, Harry
    Scott, Janet
    Edison, Paul
    BMJ MEDICINE, 2022, 1 (01):
  • [46] COVID-19: Challenges of Viral Variants
    Jacobs, Jana L.
    Haidar, Ghady
    Mellors, John W.
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 31 - 53
  • [47] COVID-19 and Its Associated Variants
    Rubi, Ghazala Rubi
    MOLECULAR THERAPY, 2024, 32 (04) : 739 - 739
  • [48] COVID-19 Variants and Vaccine Development
    Zhao, Ziyao
    Bashiri, Sahra
    Ziora, Zyta M.
    Toth, Istvan
    Skwarczynski, Mariusz
    VIRUSES-BASEL, 2024, 16 (05):
  • [49] A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
    Zachary LaJoie
    Thomas Usherwood
    Shailen Sampath
    Vikas Srivastava
    Scientific Reports, 12
  • [50] Immunopathogenesis and Immunogenetic Variants in COVID-19
    Sagulkoo, Pakorn
    Plaimas, Kitiporn
    Suratanee, Apichat
    Simao, Andrea Name Colado
    Reiche, Edna Maria Vissoci
    Maes, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (22) : 1780 - 1797